1Q95 image
Entry Detail
PDB ID:
1Q95
Keywords:
Title:
Aspartate Transcarbamylase (ATCase) of Escherichia coli: A New Crystalline R State Bound to PALA, or to Product Analogues Phosphate and Citrate
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2003-08-22
Release Date:
2004-06-08
Method Details:
Experimental Method:
Resolution:
2.46 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Aspartate carbamoyltransferase catalytic chain
Chain IDs:A, B, C, D, E, F
Chain Length:310
Number of Molecules:6
Biological Source:Escherichia coli
Polymer Type:polypeptide(L)
Description:Aspartate carbamoyltransferase regulatory chain
Chain IDs:G, H, I, J, K, L
Chain Length:153
Number of Molecules:6
Biological Source:Escherichia coli
Primary Citation
Aspartate Transcarbamylase (ATCase) of Escherichia coli: A New Crystalline R-State Bound to PALA, or to Product Analogues Citrate and Phosphate
Biochemistry 43 6415 6421 (2004)
PMID: 15157075 DOI: 10.1021/bi030213b

Abstact

Structures of the R-state of Escherichia coli ATCase maintained with carbamyl phosphate and succinate, phosphonoacetamide and malonate, or N-phosphonacetyl-l-aspartate (PALA) have previously been made in the space group P321, in which the two independent r (regulatory) and two independent c (catalytic) chains are repeated by crystallographic symmetry to yield the holoenzyme c(6)r(6), ((c(3))(2)(r(2))(3)). The exploration of a new crystalline R-state P2(1)2(1)2(1) was undertaken to examine the c(3).c(3) expansion of 11 A in the T-to-R transition, and to further test whether intermolecular contacts influence the binding of PALA. The results show that the expansion along the 3-fold axis is 10 A, and that the binding modes of the six crystallographic independent PALA molecules are virtually identical to one another, and to modes described previously. As further test, the PALA, a bisubstrate analogue, was displaced by citrate and phosphate, where citrate is an analogue of product carbamylaspartate. The results support the conclusions about the binding of the three previously studied analogues, and further support, within about 0.5 A, the structure proposed for the transition state [Gouaux, J. E., Krause, K. L., and Lipscomb, W. N. (1987) Biochem. Biophys. Res. Commun. 142, 893-897; Jin, L., Stec, B., Lipscomb, W. N., and Kantrowitz, E. R. (1999) Proteins: Struct., Funct., Genet. 37, 729-742].

Legend

Protein

Chemical

Disease

Primary Citation of related structures